Background: Infections caused by community-acquired respiratory viruses (CARV) are very common among lung transplant recipients and have been linked to acute rejection and chronic lung allograft dysfunction (CLAD). However, the clinical relevance of CARV detection in donor-recipient pairs at the time of lung transplantation remains unclear. Methods: Post hoc analysis of the Pneumoarray study, evaluating the clinical significance of incidentally detected CARV identified by syndromic molecular panels (PNplus) in BAL samples collected 72 h after transplantation from donors and recipients. Results: Among 53 donor-recipient pairs, CARV were identified in 7 (13.2%) and 11 (20.8%) BAL samples from donors and recipients, respectively. Unadjusted analyses showed a link between CARV PNplus positivity in donor samples and longer hospitalization (Δ+30.3 days, 95% CI 7.1–53.5; p = 0.011). Any CARV PNplus positivity during the transplant episode also indicated a potential link with longer hospital stays (Δ+19.2 days, 95% CI 1.4–37.0; p = 0.035). Donor CARV PNplus positivity showed a signal suggesting a potential association with higher odds of CLAD within 12 months (OR 8.40, 95% CI 0.84–83.89; p = 0.030). CARV PNplus positivity in the recipient for rhinovirus indicated a potential link with baseline lung allograft dysfunction (p = 0.016), while no other relationships were observed between clinical outcomes and being PNplus positive for a viral pathogen. Conclusion: CARV genome detection in donor BAL samples was numerically associated with longer posttransplant hospitalization, and a potential signal between rhinovirus detection in recipient BAL and baseline lung allograft dysfunction was observed. However, these findings should be regarded as exploratory and hypothesis-generating, and they do not support the routine baseline screening for CARV in lung transplant donor-recipient pairs. (Figure presented.).

Incidental Detection of Respiratory Viruses in Lung Transplant Donor-Recipient Pairs: Exploratory Associations with Clinical Outcomes in a Post Hoc Analysis / A. Lombardi, L.C.M.. - In: TRANSPLANT INFECTIOUS DISEASE. - ISSN 1399-3062. - (2026), pp. e70275.1-e70275.7. [Epub ahead of print] [10.1111/tid.70275]

Incidental Detection of Respiratory Viruses in Lung Transplant Donor-Recipient Pairs: Exploratory Associations with Clinical Outcomes in a Post Hoc Analysis

A. Lombardi
Co-primo
;
L.C. Morlacchi
Co-primo
;
L. Rosso;C. Alteri;F. Blasi;G. Grasselli;M. Nosotti
Penultimo
;
A. Bandera
Ultimo
2026

Abstract

Background: Infections caused by community-acquired respiratory viruses (CARV) are very common among lung transplant recipients and have been linked to acute rejection and chronic lung allograft dysfunction (CLAD). However, the clinical relevance of CARV detection in donor-recipient pairs at the time of lung transplantation remains unclear. Methods: Post hoc analysis of the Pneumoarray study, evaluating the clinical significance of incidentally detected CARV identified by syndromic molecular panels (PNplus) in BAL samples collected 72 h after transplantation from donors and recipients. Results: Among 53 donor-recipient pairs, CARV were identified in 7 (13.2%) and 11 (20.8%) BAL samples from donors and recipients, respectively. Unadjusted analyses showed a link between CARV PNplus positivity in donor samples and longer hospitalization (Δ+30.3 days, 95% CI 7.1–53.5; p = 0.011). Any CARV PNplus positivity during the transplant episode also indicated a potential link with longer hospital stays (Δ+19.2 days, 95% CI 1.4–37.0; p = 0.035). Donor CARV PNplus positivity showed a signal suggesting a potential association with higher odds of CLAD within 12 months (OR 8.40, 95% CI 0.84–83.89; p = 0.030). CARV PNplus positivity in the recipient for rhinovirus indicated a potential link with baseline lung allograft dysfunction (p = 0.016), while no other relationships were observed between clinical outcomes and being PNplus positive for a viral pathogen. Conclusion: CARV genome detection in donor BAL samples was numerically associated with longer posttransplant hospitalization, and a potential signal between rhinovirus detection in recipient BAL and baseline lung allograft dysfunction was observed. However, these findings should be regarded as exploratory and hypothesis-generating, and they do not support the routine baseline screening for CARV in lung transplant donor-recipient pairs. (Figure presented.).
Community‐acquired respiratory viruses; Lung transplantation; Syndromic molecular panel;
Settore MEDS-13/A - Chirurgia toracica
Settore MEDS-03/A - Microbiologia e microbiologia clinica
Settore MEDS-07/A - Malattie dell'apparato respiratorio
Settore MEDS-10/B - Malattie infettive
Settore MEDS-23/A - Anestesiologia
2026
10-lug-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
Transpl Infect Dis (Incidental Detection...).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 402.32 kB
Formato Adobe PDF
402.32 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1262220
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact